OLD Category: immuno-oncology
January 25, 2018 / Mol. Therapy
Pre-existing immunity to oncolytic virus potentiates its immunotherapeutic efficacy
January 16, 2018 / Cancer Immunol. Res.
Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade
January 16, 2018 / Can. Res.
The Hippo pathway component TAZ promotes immune evasion in human cancer through PD-L1
January 16, 2018 / Nat. Commun.
DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer
January 16, 2018 / Mol. Therapy
B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors
January 10, 2018 / BMC. Biol.
A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancer
January 8, 2018 / Cancer Cell
TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer
December 19, 2017 / J. Immunother. Cancer
Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
December 19, 2017 / Immunity
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
December 11, 2017 / J. Neuropathol. Exp. Neurol.
Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms
November 28, 2017 / Oncotarget